GSK-256073
- Generic Name
- GSK-256073
A Phase 1 Study to Evaluate the Effect of GSK256073, an HM74A Receptor Agonist, on Glucose and NEFA Levels in Type 2 Diabetics
- First Posted Date
- 2010-06-22
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 39
- Registration Number
- NCT01147861
- Locations
- 🇺🇸
GSK Investigational Site, San Antonio, Texas, United States
Study to Test GSK256073 in Patients With Dyslipidemia
Phase 2
Completed
- Conditions
- DyslipidaemiasDyslipidemias
- Interventions
- First Posted Date
- 2009-05-18
- Last Posted Date
- 2019-12-05
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 80
- Registration Number
- NCT00903617
- Locations
- 🇺🇸
GSK Investigational Site, Seattle, Washington, United States
Repeat Dose Food Effect Study of GSK256073F in Healthy Adult Subjects
- First Posted Date
- 2008-12-15
- Last Posted Date
- 2017-06-05
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 30
- Registration Number
- NCT00808093
- Locations
- 🇺🇸
GSK Investigational Site, Baltimore, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath